HuGE Literature Finder
|
||
Records 1-100
|
V617F-independent upregulation of JAK2 gene expression in patients with inflammatory bowel disease.
Journal of cellular biochemistry 2019 May . Asadzadeh-Aghdaei Hamid, Mashayekhi Kazem, Koushki Khadijeh, Azimzadeh Pedram, Rostami-Nejad Mohammad, Amani Davar, Chaleshi Vahid, Haftcheshmeh Saeed Mohammadian, Sahebkar Amirhossein, Zali Mohammad Re |
|
Effects of polymorphic DNA genes involved in BER and caspase pathways on the clinical outcome of myeloproliferative neoplasms under treatment with hydroxyurea.
Molecular medicine reports 2018 Oct . Azevedo Ana P, Silva Susana N, Reichert Alice, Lima Fernando, Júnior Esmeraldina, Rueff Jo |
|
Classical Philadelphia-negative myeloproliferative neoplasms: focus on mutations and JAK2 inhibitors.
Medical oncology (Northwood, London, England) 2018 Aug 35 (9): 119. Helbig Grzego |
|
Selective testing for calreticulin gene mutations in patients with splanchnic vein thrombosis: A prospective cohort study.
Journal of hepatology 2017 May . Poisson Johanne, Plessier Aurélie, Kiladjian Jean-Jacques, Turon Fanny, Cassinat Bruno, Andreoli Annalisa, De Raucourt Emmanuelle, Goria Odile, Zekrini Kamal, Bureau Christophe, Lorre Florence, Cervantes Francisco, Colomer Dolors, Durand François, Garcia-Pagan Juan-Carlos, Casadevall Nicole, Valla Dominique-Charles, Rautou Pierre-Emmanuel, Marzac Christophe, |
|
[Mutation of CALR Gene in Patients with Chronic Myeloproliferative Neoplasm and Its Clinical Significance].
Zhongguo shi yan xue ye xue za zhi 2017 Feb 25 (1): 151-156. Tang Qin, Zhang Xiu-Wen, Xia Lei, Jiang Nai- |
|
[The development and comparative approbation of methods of increasing sensitivity of detection of mutation V617F in gene JAK2 by pyro-sequencing].
Klinicheskaia laboratornaia diagnostika 2017 Feb 62 (2): 125-8. Dunaeva E A, Mironov K O, Subbotina T N, Olkhovsky I A, Shipulin G |
|
Estimation of diagnosis and prognosis in ET by assessment of CALR and JAK2(V617F) mutations and laboratory findings: a meta-analysis.
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2017 Feb . Saki N, Shirzad R, Rahim F, Saki Malehi |
|
[Clinical features of essential thrombocythemia and primary myelofibrosis, depending on the molecular characteristics of disease].
Terapevticheskii arkhiv 2017 89 (7): 4-9. Melikyan A L, Subortseva I N, Sudarikov A B, Kovrigina A M, Gilyazitdinova E A, Kolosheinova T I, Abdullaev A O, Treglazova S |
|
Low frequency of V617F mutation in JAK2 gene in Indian patients with hepatic venous outflow obstruction and extrahepatic portal venous obstruction.
Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 2016 Sep . Rai Praveer, Kumar Pankaj, Mishra Swapnil, Aggarwal Rake |
|
Re: Prognostic value of CALR vs. JAK2V617F mutations on splenomegaly, leukemic transformation, thrombosis, and overall survival in patients with primary fibrosis: a meta-analysis.
Annals of hematology 2016 Sep . Kourie Hampig Raphael, Ameye Lieveke, Paesmans Marianne, Bron Dominiq |
|
Coexistence of JAK2 and CALR mutations and their clinical implications in patients with essential thrombocythemia.
Oncotarget 2016 Jul . Min-Gu Kang, Hyun-Woo Choi, Jun Hyung Lee, Yong Jun Choi, Hyun-Jung Choi, Jong-Hee Shin, Soon-Pal Suh, Szardenings Michael, Hye-Ran Kim, Myung-Geun Sh |
|
Prognostic value of CALR vs. JAK2V617F mutations on splenomegaly, leukemic transformation, thrombosis, and overall survival in patients with primary fibrosis: a meta-analysis.
Annals of hematology 2016 Jul . Pei Yu-Qing, Wu Yue, Wang Fei, Cui W |
|
Thrombotic risk correlates with mutational status in true-essential thrombocythemia.
European journal of clinical investigation 2016 Jun . Bertozzi I, Peroni E, Coltro G, Bogoni G, Cosi E, Santarossa C, Fabris F, Randi M |
|
Calreticulin variant stratified driver mutational status and prognosis in essential thrombocythemia.
American journal of hematology 2016 May 91 (5): 503-6. Elala Yoseph C, Lasho Terra L, Gangat Naseema, Finke Christy, Barraco Daniela, Haider Mahnur, Abou Hussein Ahmed K, Hanson Curtis A, Ketterling Rhett P, Pardanani Animesh, Tefferi Ayal |
|
Microparticles phenotypes are associated with driver mutations and distinct thrombotic risks in Essential Thrombocythaemia.
Haematologica 2016 May . Charpentier Agnès, Lebreton Aurélien, Rauch Antoine, Bauters Anne, Trillot Nathalie, Nibourel Olivier, Tintillier Véronique, Wemeau Mathieu, Demory Jean-Loup, Preudhomme Claude, Jude Brigitte, Lecompte Thomas, Cambier Nathalie, Susen Soph |
|
Molecular biomarkers of thrombosis in myeloproliferative neoplasms.
Thrombosis research 2016 Apr 140 Suppl 1 S71-5. Barbui Tiziano, Falanga An |
|
PO-19 - Platelet (PLT) adhesion under flow condition in essential thrombocythemia (ET) and polycythemia vera (PV) is variably influenced according to patient mutational status.
Thrombosis research 2016 Apr 140 Suppl 1 S183. Vignoli A, Tessarolo S, Marchetti M, Gamba S, Piras F, Finazzi G, van der Meijden P E J, Swieringa F, Ten Cate H, Heemskerk J W M, Rambaldi A, Falanga |
|
Unbiased pro-thrombotic features at diagnosis in 977 thrombocythemic patients with Philadelphia-negative chronic myeloproliferative neoplasms.
Leukemia research 2016 Apr 46 18-25. Gugliotta Luigi, Iurlo Alessandra, Gugliotta Gabriele, Tieghi Alessia, Specchia Giorgina, Gaidano Gianluca, Scalzulli Potito R, Rumi Elisa, Dragani Alfredo, Martinelli Vincenzo, Santoro Cristina, Randi Maria Luigia, Tagariello Giuseppe, Candoni Anna, Cattaneo Daniele, Ricco Alessandra, Palmieri Raffaele, Liberati Marina A, Langella Maria, Rago Angela, Bergamaschi Micaela, Monari Paola, Miglio Rossella, Santoro Umberto, Cacciola Rossella, Rupoli Serena, Mastrullo Lucia, Musto Pellegrino, Mazzucconi Maria Gabriella, Vignetti Marco, Cortelezzi Agostino, Vianelli Nicola, Martino Bruno, Stefano Valerio De, Passamonti Francesco, Vannucchi Alessandro M, |
|
Improved Survival of Calreticulin-Mutated Patients Compared With Janus Kinase 2 in Primary Myelofibrosis: A Meta-Analysis.
Clinical lymphoma, myeloma & leukemia 2016 Feb . Kourie Hampig Raphael, Ameye Lieveke, Paesmans Marianne, Bron Dominiq |
|
Primary thrombophilia in Mexico: a single tertiary referral hospital experience.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2016 Jan . Lacayo-Leñero Dennis, Hernández-Hernández Darinel, Valencia-Martínez Andrés, Barrales-Benítez Olga, Vargas-Ruiz Angel |
|
Impact of JAK2V617F Mutation Burden on Disease Phenotype in Chinese Patients with JAK2V617F-positive Polycythemia Vera (PV) and Essential thrombocythemia (ET).
International journal of medical sciences 2016 13 (1): 85-91. Zhao Shixiang, Zhang Xiang, Xu Yang, Feng Yufeng, Sheng Wenhong, Cen Jiannong, Wu Depei, Han Y |
|
Specifics of the course and the clinical pictures of essential thrombocythemia depending on the JAK2V617F status of the patients.
Problemy radiatsiinoi medytsyny ta radiobiolohii 2015 Dec 20 399-413. Mishcheniuk O Y, Kostukevich O M, Dmytrenko I V, Klymenko S |
|
Co-occurrence of myeloproliferative neoplasms and solid tumors is attributed to a synergism between cytoreductive therapy and the common TERT polymorphism rs2736100.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2015 Oct . Krahling Tunde, Balassa Katalin, Kiss Katalin P, Bors Andras, Batai Arpad, Halm Gabriella, Egyed Miklos, Fekete Sandor, Remenyi Peter, Masszi Tamas, Tordai Attila, Andrikovics Hajnal |
|
Prevalence of JAK2V617F mutation in deep venous thrombosis patients and its clinical significance as a thrombophilic risk factor: Indian perspective.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2015 Sep 21 (6): 579-83. Singh Neha, Sharma Amit, Sazawal Sudha, Ahuja Ankur, Upadhyay Ashish, Mahapatra Manoranjan, Saxena Re |
|
Thrombophilia Profile in Budd-Chiari Syndrome and Splanchnic Vein Thrombosis: A Study from Western India.
The Journal of the Association of Physicians of India 2015 Sep 63 (9): 32-5. Sawant Prabha, Vashishtha Chitranshu, Nasa Mukesh, Parikh Pathik, Patel Jignesh, Agasti Anan |
|
Association of factor V Leiden, Janus kinase 2, prothrombin and MTHFR mutations with primary Budd-Chiari syndrome in Egyptian patients.
Journal of gastroenterology and hepatology 2015 Aug . El Sebay Hatem M, Safan Manal A, Daoud Ashraf A, Tayel Safaa I, Nouh Alaa, El Shafie Shym |
|
Genetic Risk Factors of Venous Thromboembolism in the East Algerian Population.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2015 Aug . Moussaoui S, Saussoy P, Ambroise J, Defour J P, Zouitene R, Sifi K, Abadi |
|
Genetic determinants of tissue factor pathway inhibitor plasma levels.
Thrombosis and haemostasis 2015 Jul 114 (2): 245-57. Dennis J, Kassam I, Morange P-E, Trégouët D-A, Gagnon |
|
JAK2 V617F, MPL, and CALR mutations in essential thrombocythaemia and major thrombotic complications: a single-institute retrospective analysis.
Pathology oncology research : POR 2015 Jul 21 (3): 751-8. Pósfai Éva, Marton Imelda, Király Péter Attila, Kotosz Balázs, Kiss-László Zsuzsanna, Széll Márta, Borbényi Zi |
|
Thrombophilic factor analysis in cirrhotic patients with portal vein thrombosis.
Journal of thrombosis and thrombolysis 2015 Jul 40 (1): 54-60. Saugel Bernd, Lee Marcel, Feichtinger Stephanie, Hapfelmeier Alexander, Schmid Roland M, Siveke Jens |
|
Impaired leucocyte activation is underlining the lower thrombotic risk of essential thrombocythaemia patients with CALR mutations as compared with those with the JAK2 mutation.
British journal of haematology 2015 Jun . Torregrosa Jose M, Ferrer-Marín Francisca, Lozano María L, Moreno Maria J, Martinez Constantino, Anton Ana I, Rivera José, Vicente Vicen |
|
Increasing procoagulant activity of circulating microparticles in patients with Philadelphia-negative myeloproliferative neoplasms: a single-centre experience.
Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis 2015 Jun 26 (4): 448-53. Kissova Jarmila, Ovesna Petra, Bulikova Alena, Zav?elova Ji?ina, Penka Mirosl |
|
Mutations and long-term outcome of 217 young patients with essential thrombocythemia or early primary myelofibrosis.
Leukemia 2015 Jun 29 (6): 1344-9. Palandri F, Latagliata R, Polverelli N, Tieghi A, Crugnola M, Martino B, Perricone M, Breccia M, Ottaviani E, Testoni N, Merli F, Aversa F, Alimena G, Cavo M, Martinelli G, Catani L, Baccarani M, Vianelli |
|
Discrepancies between bone marrow histopathology and clinical phenotype in BCR-ABL1-negative myeloproliferative neoplasms associated with splanchnic vein thrombosis.
Leukemia research 2015 May 39 (5): 525-9. Gianelli Umberto, Iurlo Alessandra, Cattaneo Daniele, Bossi Anna, Cortinovis Ivan, Augello Claudia, Moro Alessia, Savi Federica, Castelli Roberto, Brambilla Cecilia, Bianchi Paola, Primignani Massimo, Cortelezzi Agostino, Bosari Silva |
|
Impact of JAK2V617F Mutational Status on Phenotypic Features in Essential Thrombocythemia and Primary Myelofibrosis.
Turkish journal of haematology : official journal of Turkish Society of Haematology 2015 Apr . Yönal Ipek, Da?lar Aday Aynur, Akadam Teker Ba?ak, Ceylan Y?lmaz, Nalcac? Meliha, Yavuz Akif Selim, Sarg?n Fatma Den |
|
[Essential thrombocythemia: baseline characteristics and risk factors for survival and thrombosis in a series of 214 patients].
Medicina clínica 2015 Mar 144 (6): 247-53. Angona Anna, Alvarez-Larrán Alberto, Bellosillo Beatriz, Martínez-Avilés Luz, Garcia-Pallarols Francesc, Longarón Raquel, Ancochea Àgueda, Besses Carl |
|
Incidence, clinical features, and prognostic impact of CALR exon 9 mutations in essential thrombocythemia and primary myelofibrosis: an experience of a single tertiary hospital in Korea.
Annals of laboratory medicine 2015 Mar 35 (2): 233-7. Park Sang Hyuk, Kim Shine Young, Lee Sun Min, Yi Jongyoun, Kim In-Suk, Kim Hyung Hoi, Chang Chulhun Ludgerus, Lee Eun Yup, Song Moo-Kon, Shin Ho-Jin, Chung Joo Se |
|
Influence of the JAK2 V617F Mutation and Inherited Thrombophilia on the Thrombotic Risk among Patients with Myeloproliferative Disorders.
Mædica 2015 Mar 10 (1): 27-32. Tevet Mihaela, Ionescu Razvan, Dragan Cornel, Lupu Anca Roxa |
|
Diagnostic value of the JAK2 V617F mutation for latent chronic myeloproliferative disorders in patients with Budd-Chiari syndrome and/or portal vein thrombosis.
The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology 2015 Jan 26 (1): 42-8. Karaköse Süleyman, Oruç Nevin, Zengin Melia, Akarca Ulus Salih, Ersöz Gal |
|
Mutations and thrombosis in essential thrombocythemia: prognostic interaction with age and thrombosis history.
European journal of haematology 2015 Jan 94 (1): 31-6. Gangat Naseema, Wassie Emnet A, Lasho Terra L, Finke Christy, Ketterling Rhett P, Hanson Curtis A, Pardanani Animesh, Wolanskyj Alexandra P, Maffioli Margherita, Casalone Rosario, Passamonti Francesco, Tefferi Ayal |
|
Role of calreticulin mutations in the aetiological diagnosis of splanchnic vein thrombosis.
Journal of hepatology 2015 Jan 62 (1): 72-4. Turon Fanny, Cervantes Francisco, Colomer Dolors, Baiges Anna, Hernández-Gea Virginia, Garcia-Pagán Juan Carl |
|
Calreticulin mutations and long-term survival in essential thrombocythemia.
Leukemia 2014 Dec 28 (12): 2300-3. Tefferi A, Wassie E A, Lasho T L, Finke C, Belachew A A, Ketterling R P, Hanson C A, Pardanani A, Gangat N, Wolanskyj A |
|
Frequencies, clinical characteristics, and outcome of somatic CALR mutations in JAK2-unmutated essential thrombocythemia.
Annals of hematology 2014 Dec 93 (12): 2029-36. Chen Chih-Cheng, Gau Jyh-Pyng, Chou Hui-Ju, You Jie-Yu, Huang Cih-En, Chen Yi-Yang, Lung Jrhau, Chou Yi-Sheng, Leu Yu-Wei, Lu Chang-Hsien, Lee Kuan-Der, Tsai Ying-Hua |
|
JAK2 V617F mutation status of 232 patients diagnosed with chronic myeloproliferative neoplasms.
Clinical lymphoma, myeloma & leukemia 2014 Dec 14 (6): 525-33. Payzin Kadriye Bahriye, Savasoglu Kaan, Alacacioglu Inci, Ozdemirkiran Fusun, Mutlu Belgin Berber, Bener Sadi, Calli Aylin Orgen, Kucukzeybek Betul Bolat, Aksun Sali |
|
The JAK2 46/1 haplotype (GGCC) in myeloproliferative neoplasms and splanchnic vein thrombosis: a pooled analysis of 26 observational studies.
Annals of hematology 2014 Nov 93 (11): 1845-52. Li Sheng-Li, Zhang Pei-Jin, Sun Gui-Xiang, Lu Zhao-J |
|
Clinical effect of driver mutations of JAK2, CALR, or MPL in primary myelofibrosis.
Blood 2014 Aug 124 (7): 1062-9. Rumi Elisa, Pietra Daniela, Pascutto Cristiana, Guglielmelli Paola, Martínez-Trillos Alejandra, Casetti Ilaria, Colomer Dolors, Pieri Lisa, Pratcorona Marta, Rotunno Giada, Sant'Antonio Emanuela, Bellini Marta, Cavalloni Chiara, Mannarelli Carmela, Milanesi Chiara, Boveri Emanuela, Ferretti Virginia, Astori Cesare, Rosti Vittorio, Cervantes Francisco, Barosi Giovanni, Vannucchi Alessandro M, Cazzola Mario, |
|
JAK2V617F monitoring in polycythemia vera and essential thrombocythemia: clinical usefulness for predicting myelofibrotic transformation and thrombotic events.
American journal of hematology 2014 May 89 (5): 517-23. Alvarez-Larrán Alberto, Bellosillo Beatriz, Pereira Arturo, Kerguelen Ana, Hernández-Boluda Juan Carlos, Martínez-Avilés Luz, Fernández-Rodríguez Concepción, Gómez Montse, Lombardía Luis, Angona Anna, Ancochea Agueda, Senín Alicia, Longarón Raquel, Navarro Blanca, Collado María, Besses Carl |
|
CALR exon 9 mutations are somatically acquired events in familial cases of essential thrombocythemia or primary myelofibrosis.
Blood 2014 Apr 123 (15): 2416-9. Rumi Elisa, Harutyunyan Ashot S, Pietra Daniela, Milosevic Jelena D, Casetti Ilaria C, Bellini Marta, Them Nicole C C, Cavalloni Chiara, Ferretti Virginia V, Milanesi Chiara, Berg Tiina, Sant'Antonio Emanuela, Boveri Emanuela, Pascutto Cristiana, Astori Cesare, Kralovics Robert, Cazzola Mario, |
|
Impact of calreticulin mutations on clinical and hematological phenotype and outcome in essential thrombocythemia.
Blood 2014 Mar 123 (10): 1552-5. Rotunno Giada, Mannarelli Carmela, Guglielmelli Paola, Pacilli Annalisa, Pancrazzi Alessandro, Pieri Lisa, Fanelli Tiziana, Bosi Alberto, Vannucchi Alessandro M, |
|
JAK2 or CALR mutation status defines subtypes of essential thrombocythemia with substantially different clinical course and outcomes.
Blood 2014 Mar 123 (10): 1544-51. Rumi Elisa, Pietra Daniela, Ferretti Virginia, Klampfl Thorsten, Harutyunyan Ashot S, Milosevic Jelena D, Them Nicole C C, Berg Tiina, Elena Chiara, Casetti Ilaria C, Milanesi Chiara, Sant'antonio Emanuela, Bellini Marta, Fugazza Elena, Renna Maria C, Boveri Emanuela, Astori Cesare, Pascutto Cristiana, Kralovics Robert, Cazzola Mario, |
|
The relationship between factor V Leiden, prothrombin G20210A, and MTHFR mutations and the first major thrombotic episode in polycythemia vera and essential thrombocythemia.
Annals of hematology 2014 Feb 93 (2): 203-9. Trifa Adrian P, Cucuianu Andrei, Popp Radu A, Coad? Camelia A, Costache Roxana M, Militaru Mariela S, Vesa ?tefan C, Pop Ioan |
|
JAK2 V617F mutation and 46/1 haplotype in Chinese Budd-Chiari syndrome patients.
Journal of gastroenterology and hepatology 2014 Jan 29 (1): 208-14. Wang Hui, Sun Guixiang, Zhang Peijin, Zhang Jing, Gui Er, Zu Maoheng, Jia Enzhi, Xu Hao, Xu Lichun, Zhang Jinpeng, Lu Zhaoj |
|
JAK2V617F allele burden is associated with thrombotic mechanisms activation in polycythemia vera and essential thrombocythemia patients.
International journal of hematology 2014 Jan 99 (1): 32-40. Coucelo Margarida, Caetano Gonçalo, Sevivas Teresa, Almeida Santos Susana, Fidalgo Teresa, Bento Celeste, Fortuna Manuela, Duarte Marta, Menezes Cristina, Ribeiro M Letíc |
|
Phospholipid-dependent procoagulant activity is highly expressed by circulating microparticles in patients with essential thrombocythemia.
American journal of hematology 2014 Jan 89 (1): 68-73. Marchetti Marina, Tartari Carmen J, Russo Laura, Panova-Noeva Marina, Leuzzi Annamaria, Rambaldi Alessandro, Finazzi Guido, Woodhams Barry, Falanga An |
|
Association between thromboembolic events and the JAK2 V617F mutation in myeloproliferative neoplasms.
The Kurume medical journal 2014 60 (3-4): 89-97. Takata Yuka, Seki Ritsuko, Kanajii Taisuke, Nohara Masayuki, Koteda Satoko, Kawaguchi Kuniki, Nomura Kei, Nakamura Takayuki, Morishige Satoshi, Oku Eijirou, Osaki Koichi, Hashiguchi Emichitoshi, Mouri Fumihiko, Yoshimoto Koji, Nagafuji Koji, Okamura Takas |
|
JAK2V617F mutation status and allele burden in classical Ph-negative myeloproliferative neoplasms in Japan.
International journal of hematology 2014 99 (5): 625-34. Edahiro Yoko, Morishita Soji, Takahashi Kochi, Hironaka Yumi, Yahata Yuriko, Sunami Yoshitaka, Shirane Shuichi, Tsutsui Miyuki, Noguchi Masaaki, Koike Michiaki, Imai Kiyotoshi, Kirito Keita, Noda Naohiro, Sekiguchi Yuji, Tsuneda Satoshi, Ohsaka Akimichi, Araki Marito, Komatsu Nor |
|
JAK2 mutation: an aid in the diagnosis of occult myeloproliferative neoplasms in patients with major intraabdominal vein thrombosis and normal blood counts.
The Israel Medical Association journal : IMAJ 2013 Nov 15 (11): 698-700. Sarid Nadav, Eshel Rinat, Rahamim Einam, Carmiel Michal, Kirgner Ilya, Shpringer Meirav, Trestman Svetlana, Marilus Rafi, Perry Chava, Polliack Aaron, Naparstek Ella, Herishanu Ya |
|
Clinical and laboratory significance of defective P2Y(12) pathway function in patients with myeloproliferative neoplasms: a pilot study.
Acta haematologica 2013 130 (3): 3. Chang H, Shih LY, Michelson AD, Dunn P, Frelinger AL, Wang PN, Kuo MC, Lin TL, Wu JH, Tang TC |
|
Molecular characterization of Ph-negative myeloproliferative neoplasms in Ukraine.
Experimental oncology 2013 Sep 35 (3): 202-6. Mishcheniuk O Y, Kostukevich O M, Dmytrenko I V, Sholoyko V V, Prokopenko I M, Martina Z V, Pilipenko G V, Klymenko S |
|
Outcome of patients with splanchnic venous thrombosis presenting without overt MPN: a role for the JAK2 V617F mutation re-evaluation.
Thrombosis research 2013 Aug 132 (2): e99-e104. Colaizzo Donatella, Amitrano Lucio, Guardascione Maria Anna, Tiscia Giovanni Luca, D'Andrea Giovanna, Longo Vittoria A C, Grandone Elvira, Margaglione Mauriz |
|
The association of the JAK2 46/1 haplotype with non-splanchnic venous thrombosis.
Thrombosis research 2013 Aug 132 (2): e86-93. Zerjavic Katja, Zagradisnik Boris, Lokar Lidija, Krasevac Marjana G, Vokac Nadja |
|
Telomere shortening in Ph-negative chronic myeloproliferative neoplasms: a biological marker of polycythemia vera and myelofibrosis, regardless of hydroxycarbamide therapy.
Experimental hematology 2013 Jul 41 (7): 627-34. Ruella Marco, Salmoiraghi Silvia, Risso Alessandra, Carobbio Alessandra, Buttiglieri Stefano, Spatola Tiziana, Sivera Piera, Ricca Irene, Barbui Tiziano, Tarella Corrado, Rambaldi Alessand |
|
Clinical features and etiology of Budd-Chiari syndrome in Chinese patients: a single-center study.
Journal of gastroenterology and hepatology 2013 Jun 28 (6): 1061-7. Cheng Delei, Xu Hao, Lu Zhao-Jun, Hua Rong, Qiu Huan, Du Hongtao, Xu Xinjian, Zhang Ji |
|
Thrombotic risk factors in Chinese Budd-Chiari syndrome patients. An observational study with a systematic review of the literature.
Thrombosis and haemostasis 2013 May 109 (5): 878-84. Qi X, Wu F, Ren W, He C, Yin Z, Niu J, Bai M, Yang Z, Wu K, Fan D, Han |
|
Evaluation of the presence of hereditary and acquired thrombophilias in Brazilian children and adolescents with diagnoses of portal vein thrombosis.
Journal of pediatric gastroenterology and nutrition 2012 Nov 55 (5): 599-604. Ferri Priscila Menezes, Rodrigues Ferreira Alexandre, Fagundes Eleonora Druve Tavares, Xavier Sandra Guerra, Dias Ribeiro Daniel, Fernandes Ana Paula, Borges Karina Braga Gomes, Liu Shinfay Maximilian, de Melo Maria do Carmo Barros, Roquete Mariza Leitão Valadares, Penna Francisco Jo |
|
[Clinical significance of the quantification of JAK2V617F allele burden in classical Ph-negative myeloproliferative neoplasms].
Medicina clínica 2012 Oct 139 (9): 373-8. Kerguelén Fuentes Ana Esther, Hernández-Maraver Dolores, Lombardia Luis, Canales Albendea Miguel Angel, Rodriguez de la Rúa A |
|
Extrahepatic portal venous system thrombosis in recurrent acute and chronic alcoholic pancreatitis is caused by local inflammation and not thrombophilia.
The American journal of gastroenterology 2012 Oct 107 (10): 1579-85. Rebours Vinciane, Boudaoud Larbi, Vullierme Marie-Pierre, Vidaud Dominique, Condat Bertrand, Hentic Olivia, Maire Frédérique, Hammel Pascal, Ruszniewski Philippe, Lévy Philip |
|
The clinical significance of JAK2V617F mutation for Philadelphia-negative chronic myeloproliferative neoplasms in patients with splanchnic vein thrombosis.
Journal of thrombosis and thrombolysis 2012 Oct 34 (3): 388-96. Yonal Ipek, Pinarbas? Binnur, Hindilerden Fehmi, Hancer Veysel Sabri, Nalcaci Meliha, Kaymakoglu Sabahattin, Diz-Kucukkaya Reyh |
|
Janus kinase (JAK) 2 V617F mutation in Asian Indians with cerebral venous thrombosis and without overt myeloproliferative disorders.
Journal of the neurological sciences 2012 Sep . De T, Prabhakar P, Nagaraja D, Christopher R |
|
JAK2 (V617F) mutation is not associated with thrombosis in Behcet syndrome.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2012 Jul 18 (4): 421-6. Ar M Cem, Hatemi Gülen, Ekizo?lu Seda, Bilgen Hülya, Saçli Sevgi, Buyru A Nur, Soysal Teoman, Ülkü Birsen, Yazici Has |
|
Prevalence and clinical outcomes of the 46/1 haplotype, Janus kinase 2 mutations, and ten-eleven translocation 2 mutations in Budd-Chiari syndrome and their impact on thrombotic complications post liver transplantation.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2012 Jul 18 (7): 819-27. Westbrook Rachel H, Lea Nicholas C, Mohamedali Azim M, Smith Alexander E, Orr David W, Roberts Lara N, Heaton Nigel D, Wendon Julia A, O'Grady John G, Heneghan Michael A, Mufti Ghulam |
|
Inferior vena cava thrombosis and its relationship with the JAK2V617F mutation and chronic myeloproliferative disease.
Thrombosis research 2012 Jun 129 (6): 720-4. Linnemann Birgit, Kraft Christiane, Roskos Martin, Zgouras Dimitrios, Lindhoff-Last Edelga |
|
Prevalence of the JAK2V617F mutation in Chinese patients with Budd-Chiari syndrome and portal vein thrombosis: a prospective study.
Journal of gastroenterology and hepatology 2012 Jun 27 (6): 1036-43. Qi Xingshun, Zhang Cheng, Han Guohong, Zhang Wei, He Chuangye, Yin Zhanxin, Liu Zhiwei, Bai Wei, Li Ruijun, Bai Ming, Yang Zhiping, Wu Kaichun, Fan Daimi |
|
The JAK2 V617F mutation in patients with cerebral venous thrombosis.
Journal of thrombosis and haemostasis : JTH 2012 Jun 10 (6): 998-1003. Passamonti S M, Biguzzi E, Cazzola M, Franchi F, Gianniello F, Bucciarelli P, Pietra D, Mannucci P M, Martinelli |
|
Absence of JAK2V617F mutation in Chinese deep vein thrombosis patients without myeloproliferative neoplasms.
Thrombosis research 2012 May 129 (5): 664-5. Dong Bingfei, Zhang Yang, Fu Xueqi, Wang Guang |
|
Thrombocythemia and polycythemia in patients younger than 20 years at diagnosis: clinical and biologic features, treatment, and long-term outcome.
Blood 2012 Mar 119 (10): 2219-27. Giona Fiorina, Teofili Luciana, Moleti Maria Luisa, Martini Maurizio, Palumbo Giovanna, Amendola Angela, Mazzucconi Maria Gabriella, Testi Anna Maria, Pignoloni Patrizia, Orlando Sonia Maria, Capodimonti Sara, Nanni Mauro, Leone Giuseppe, Larocca Luigi Maria, Foà Rob |
|
Incidence rates and risk factors for vascular events in patients with essential thrombocythemia: a multicenter study from Korea.
Clinical lymphoma, myeloma & leukemia 2012 Feb 12 (1): 70-5. Lee Ho Sup, Park Lee Chun, Lee Eun Mi, Lee Shin Jun, Shin Seong Hoon, Im Hana, Do Kil Min, Kim Eeon Jin, Ye Byeong Jin, Song Moo Kon, Kim Sung-Hyun, Lee Sang Min, Lee Won Sik, Kim Yang S |
|
JAK2 V617F Mutation Prevalence in Myeloproliferative Neoplasms in Pernambuco, Brazil.
Genetic testing and molecular biomarkers 2012 Feb . Silva RR, Domingues Hatzlhofer BL, Machado CG, Lima AS, Albuquerque DM, Santos MN, Fertrin KY, Costa FF, Araújo AD, Bezerra MA |
|
Relevance of the JAK2V617F mutation in patients with deep vein thrombosis of the leg.
Annals of hematology 2012 Jan 91 (1): 103-7. Lauw Mandy N, Bus Erik W N, van Wulfften Palthe Alexander F Y, Coppens Michiel, Homburg Christa H, Middeldorp Saskia, van der Schoot C Ellen, Koene Harry R, Biemond Bart |
|
The C allele of JAK2 rs4495487 is an additional candidate locus that contributes to myeloproliferative neoplasm predisposition in the Japanese population.
BMC medical genetics 2012 13 (1): 6. Ohyashiki Junko H, Yoneta Masayuki, Hisatomi Hisashi, Iwabuchi Tamiko, Umezu Tomohiro, Ohyashiki Kazu |
|
[Significance of the JAK2V617F mutation in patients with chronic myeloproliferative neoplasia].
Orvosi hetilap 2011 Nov 152 (45): 1795-803. Iványi János László, Marton Eva, Plander Má |
|
Prevalence of overt myeloproliferative neoplasms and JAK2 V617F mutation in Korean patients with splanchnic vein thrombosis.
International journal of laboratory hematology 2011 Oct 33 (5): 471-6. Yoo E-H, Jang J-H, Park K-J, Gwak G-Y, Kim H-J, Kim S-H, Kim D |
|
Sex modulation of the occurrence of jak2 v617f mutation in patients with splanchnic venous thrombosis.
Thrombosis research 2011 Sep 128 (3): 233-6. Colaizzo Donatella, Tiscia Giovanni Luca, Bafunno Valeria, Amitrano Lucio, Vergura Patrizia, Lupone Maria Rosaria, Grandone Elvira, Guardascione Maria Anna, Margaglione Mauriz |
|
[JAK2V617F mutation in the patients with myeloproliferative disorder and its relation with clinical characteristics].
Zhongguo shi yan xue ye xue za zhi / Zhongguo bing li sheng li xue hui = Journal of experimental hematology / Chinese Association of Pathophysiology 2011 Aug 19 (4): 916-20. Zhu Jun-Fang, Liu Yuan, Liu Pei, Jia Ming-Feng, Cheng Juan, Zhao |
|
Impact of leukocytosis on thrombotic risk and survival in 532 patients with essential thrombocythemia: a retrospective study.
Annals of hematology 2011 Aug 90 (8): 933-8. Palandri Francesca, Polverelli Nicola, Catani Lucia, Ottaviani Emanuela, Baccarani Michele, Vianelli Nico |
|
Prognostic factors and models in polycythemia vera, essential thrombocythemia, and primary myelofibrosis.
Clinical lymphoma, myeloma & leukemia 2011 Jun 11 Suppl 1 S25-7. Passamonti Frances |
|
Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients.
Blood 2011 Jun 117 (22): 5857-9. Carobbio Alessandra, Thiele Juergen, Passamonti Francesco, Rumi Elisa, Ruggeri Marco, Rodeghiero Francesco, Randi Maria Luigia, Bertozzi Irene, Vannucchi Alessandro M, Antonioli Elisabetta, Gisslinger Heinz, Buxhofer-Ausch Veronika, Finazzi Guido, Gangat Naseema, Tefferi Ayalew, Barbui Tizia |
|
Meta-analysis: the significance of screening for JAK2V617F mutation in Budd-Chiari syndrome and portal venous system thrombosis.
Alimentary pharmacology & therapeutics 2011 May 33 (10): 1087-103. Qi X, Yang Z, Bai M, Shi X, Han G, Fan |
|
Prognostic utility of spontaneous erythroid colony formation and JAK2 mutational analysis for thrombotic events in essential thrombocythaemia.
Internal medicine journal 2011 May 41 (5): 408-15. Weston H, Cowell V, Grimmett K, Saal R, Jones M, Mills T, Gill D, Marlton P, Bird R, Mollee |
|
The JAK2 46/1 haplotype in Budd-Chiari syndrome and portal vein thrombosis.
Blood 2011 Apr 117 (15): 3968-73. Smalberg Jasper H, Koehler Edith, Darwish Murad Sarwa, Plessier Aurelie, Seijo Susana, Trebicka Jonel, Primignani Massimo, de Maat Moniek P M, Garcia-Pagan Juan-Carlos, Valla Dominique C, Janssen Harry L A, Leebeek Frank W G, |
|
Impact of common thrombophilias and JAK2 V617F on pregnancy outcomes in unselected Italian women.
Journal of thrombosis and haemostasis : JTH 2011 Mar 9 (3): 496-501. Grandone E, Colaizzo D, Tiscia G, Vergura P, Cappucci F, Greco L, Margaglione M, Martinelli P, |
|
Molecular and clinical features of the myeloproliferative neoplasm associated with JAK2 exon 12 mutations.
Blood 2011 Mar 117 (10): 2813-6. Passamonti Francesco, Elena Chiara, Schnittger Susanne, Skoda Radek C, Green Anthony R, Girodon François, Kiladjian Jean-Jacques, McMullin Mary Frances, Ruggeri Marco, Besses Carles, Vannucchi Alessandro M, Lippert Eric, Gisslinger Heinz, Rumi Elisa, Lehmann Thomas, Ortmann Christina A, Pietra Daniela, Pascutto Cristiana, Haferlach Torsten, Cazzola Mar |
|
Inflammation and thrombosis in essential thrombocythemia and polycythemia vera: different role of C-reactive protein and pentraxin 3.
Haematologica 2011 Feb 96 (2): 315-8. Barbui Tiziano, Carobbio Alessandra, Finazzi Guido, Vannucchi Alessandro M, Barosi Giovanni, Antonioli Elisabetta, Guglielmelli Paola, Pancrazzi Alessandro, Salmoiraghi Silvia, Zilio Pio, Ottomano Cosimo, Marchioli Roberto, Cuccovillo Ivan, Bottazzi Barbara, Mantovani Alberto, Rambaldi Alessandro, |
|
JAK2(V617F) allele burden in polycythemia vera correlates with grade of myelofibrosis, but is not substantially affected by therapy.
Leukemia research 2011 Feb 35 (2): 177-82. Silver Richard T, Vandris Katherine, Wang Y Lynn, Adriano Fernando, Jones Amy V, Christos Paul J, Cross Nicholas C |
|
JAK2 46/1 haplotype seems not to be associated with lower limb deep venous thrombosis.
Blood cells, molecules & diseases 2010 Oct 45 (3): 199-200. Trifa Adrian P, Cri?an Sorin, Popp Radu A, Cucuianu Andrei, Buzoianu Anca |
|
Thrombosis in myelofibrosis: prior thrombosis is the only predictive factor and most venous events are provoked.
Haematologica 2010 Oct 95 (10): 1788-91. Elliott Michelle Ann, Pardanani Animesh, Lasho Terra L, Schwager Susan M, Tefferi Ayal |
|
[Correlative study between JAK2 mutation and thrombosis in patients with myeloproliferative neoplasm.]
Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2010 Sep 31 (9): 590-593. Xia Liang, Ding Kai-Yang, Cai Xiao-Yan, Zhu Wei-Bo, Liu Xin, Yang Hui-Zhi, Wan Xiang, Wu Lin-Lin, Zeng Qing-Shu, Wu Jing-She |
|
A prospective study of 338 patients with polycythemia vera: the impact of JAK2 (V617F) allele burden and leukocytosis on fibrotic or leukemic disease transformation and vascular complications.
Leukemia 2010 Sep 24 (9): 1574-9. Passamonti F, Rumi E, Pietra D, Elena C, Boveri E, Arcaini L, Roncoroni E, Astori C, Merli M, Boggi S, Pascutto C, Lazzarino M, Cazzola |
|
Impact of JAK2V617F mutation on thrombosis and myeloid transformation in essential thrombocythemia: a multivariate analysis by Cox regression in 141 patients.
Hematology (Amsterdam, Netherlands) 2010 Aug 15 (4): 187-92. Chim C S, Sim J P, Chan C C, Kho B C, Chan J C, Wong L G, Law M, Liang R, Kwong Y |
|
Monocyte IL-2Ralpha expression is associated with thrombosis and the JAK2V617F mutation in myeloproliferative neoplasms.
Cytokine 2010 Jul 51 (1): 67-72. Goette N P, Lev P R, Heller P G, Kornblihtt L I, Korin L, Molinas F C, Marta R |
- Page last reviewed:Jul 30, 2019
- Page last updated:Aug 22, 2019
- Content source: